Notice for momelotinib (GlaxoSmithKline Australia Pty Ltd)
Active ingredients
momelotinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
film coated tablet
Indication
For the treatment of myelofibrosis
Therapeutic area
Oncology